Rb-loss is associated with high malignancy in chondrosarcoma

Oncology Reports

Volumn 15, Issue 1, 2006, Pages 89-95

  Ropke M ^a   Boltze, C ^a   Meyer, B ^a   Neumann, H W ^a   Roessner, A ^a   Schneider Stock, Regine ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Dedifferentiated chondrosarcoma; Loss of heterozygosity; Microdissection; Rb LOH; Retinoblastoma gene; Tumour progression

Indexed keywords

DNA; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; CHILD; CHONDROSARCOMA; FEMALE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; CHONDROSARCOMA; DNA, NEOPLASM; FEMALE; GENES, RETINOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RETINOBLASTOMA PROTEIN;

EID: 33644873612     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.1.89     Document Type: Article

References (29)

1. Hong FD, Huang HJ, To H, Young LJ, Oro A, Bookstein R, Lee EY and Lee WH: Structure of the human retinoblastoma gene. Proc Natl Acad Sci USA 86: 5502-5506, 1989. (Pubitemid 19185573)
2. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
3. Macleod K: Tumor suppressor genes. Curr Opin Genet Dev 10: 81-93, 2000.
4. Feugeas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P, Babin S, Thyss A, Hofman P, Terrier P, Kalifa C, Patricot LM, Brunat-Mentigny M and Oberling F: Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14: 467-472, 1996. (Pubitemid 26051009)
5. Patino-Garcia A, Pineiro ES, Diez MZ, Iturriagagoitia LG, Klussmann FA and Ariznabarreta LS: Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas. J Pediatr Hematol Oncol 25: 362-367, 2003. (Pubitemid 36569966)
6. Schneider-Stock R, Boltze C, Jaeger V, Stumm M, Seiler C, Rys J, Schutze K and Roessner A: Significance of loss of heterozygosity of the RB1 gene during tumour progression in well-differentiated liposarcomas. J Pathol 197: 654-660, 2002.
7. Wurl P, Meye A, Berger D, Lautenschlager C, Bache M, Holzhausen HJ, Schmidt H, Dralle H, Rath FW and Taubert H: Significance of retinoblastoma and Mdm2 gene expression as prognostic markers for soft tissue sarcoma. Langenbecks Arch Surg 383: 99-103, 1998. (Pubitemid 28226347)
8. Asp J, Sangiorgi L, Inerot SE, Lindahl A, Molendini L, Benassi MS and Picci P: Changes of the P16 gene, but not the P53 gene in human chondrosarcoma tissues. Int J Cancer 85: 782-786, 2000. (Pubitemid 30131465)
9. Asp J, Inerot, S, Block JA and Lindahl A: Alterations in the regulatory pathway involving P16, PRb and Cdk4 in human chondrosarcoma. J Orthop Res 19: 149-154, 2001. (Pubitemid 32288649)
10. Bovee JV, Cleton-Jansen AM, Rosenberg C, Taminiau AH, Cornelisse CJ and Hogendoorn PC: Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol 189: 454-462, 1999.
11. Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y and Sasaki MS: Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Anticancer Res 16: 2009-2015, 1996. (Pubitemid 26270717)
12. Gitelis S, Bertoni F, Picci P and Campanacci M: Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am 63: 1248-1257, 1981. (Pubitemid 11022301)
13. Aigner T: Towards a new understanding and classification of chondrogenic neoplasias of the skeleton biochemistry and cell biology of chondrosarcoma and its variants. Virchows Arch 441: 219-230, 2002.
14. Dailey L, Laplantine E, Priore R and Basilico CA: Network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol 161: 1053-1066, 2003. (Pubitemid 36870168)
15. Rossi F, MacLean HE, Yuan W, Francis RO, Semenova E, Lin CS, Kronenberg HM and Cobrinik D: P107 and P130 coordinately regulate proliferation, Cbfa1 expression, and hypertrophic differentiation during endochondral bone development. Dev Biol 247: 271-285, 2002. (Pubitemid 34734864)
16. Schneider-Stock R, Walter H, Radig K, Rys J, Bosse A, Kuhnen C, Hoang-Vu C and Roessner A: MDM2 amplification and loss of heterozygosity at Rb and P53 genes: no simultaneous alterations in the oncogenesis of liposarcomas. J Cancer Res Clin Oncol 124: 532-540, 1998. (Pubitemid 28513115)
17. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ and Allen RC: Analysis of the VNTR locus D1S80 by the PCR followed by high resolution PAGE. Am J Hum Genet 48: 137-144, 1991. (Pubitemid 21903036)
18. Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ, Pass HI, Picci P, Levine AS and Carbone M: Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem 63: 37-50, 1996. (Pubitemid 26329785)
19. Eisenberg MB, Woloschak M, Sen C and Wolfe D: Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas. Surg Neurol 47: 156-160, 1997.
20. Kleist B, Poetsch M, Lang C, Bankau A, Lorenz G, Jundt G, Suess-Fridrich K and Wolf E: Clear cell chondrosarcoma of the larynx: a case report of a rare histologic variant in an uncommon localization. Am J Surg Pathol 26: 386-392, 2002. (Pubitemid 34184465)
21. Bovee JV, Cleton-Jansen AM, Kuipers-Dijkshoorn NJ, Taminiau AH, van den Broek LJ, Cornelisse CJ and Hogendoorn PC: Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosomes Cancer 26: 237-246, 1999. (Pubitemid 29468344)
22. Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R and Lee EY: The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329: 642-645, 1987. (Pubitemid 17140117)
23. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY and Lee EY: Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235: 1394-1399, 1987. (Pubitemid 17041661)
24. Coughlan B, Feliz A, Ishida T, Czerniak B and Dorfman HD: P53 expression and DNA ploidy of cartilage lesions. Hum Pathol 26: 620-624, 1995.
25. Dobashi Y, Sugimura H, Sato A, Hirabayashi T, Kanda H, Kitagawa T, Kawaguchi N, Imamura T and Machinami R: Possible association of P53 overexpression and mutation with high-grade chondrosarcoma. Diagn Mol Pathol 2: 257-263, 1993. (Pubitemid 24001532)
26. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS and Yamamuro T: P53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68: 1134-1139, 1993. (Pubitemid 23356665)
27. Sakamoto A, Oda Y, Adachi T, Oshiro Y, Tamiya S, Tanaka K, Matsuda S, Iwamoto Y and Tsuneyoshi M: H-Ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis. Mod Pathol 14: 343-349, 2001. (Pubitemid 32298920)
28. Asp J, Brantsing C, Benassi MS, Inerot S, Sangiorgi L, Picci P and Lindahl A: Changes in P14 (ARF) do not play a primary role in human chondrosarcoma tissues. Int J Cancer 93: 703-705, 2001. (Pubitemid 32695120)
29. Ropke M, Boltze C, Neumann HW, Roessner A and Schneider-Stock R: Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma. Pathol Res Pract 199: 437-444, 2003. (Pubitemid 36974832)